Medical Antihyperglycaemic Treatment of Type 2 Diabetes Mellitus Update of the evidence-based guideline of the German Diabetes Association

被引：67

作者：

Matthaei, S. ^{[1
]}

Bierwirth, R.

Fritsche, A. ^{[2
]}

Gallwitz, B. ^{[2
]}

Haering, H. -U. ^{[2
]}

Joost, H. -G. ^{[3
]}

Kellerer, M. ^{[4
]}

Kloos, Ch. ^{[5
]}

Kunt, T.

Nauck, M. ^{[6
]}

Schernthaner, G. ^{[7
]}

Siegel, E. ^{[8
]}

Thienel, F. ^{[1
]}

机构：

[1] Diabet Zentrum Quakenbruck, Quakenbruck, Germany

[2] Univ Tubingen, Med Klin 4, Tubingen, Germany

[3] Deutsch Inst Ernahrungsforsch, Bergholz Rehbrucke, Germany

[4] Marienhosp Stuttgart, Zentrum Innere Med Diabetol & Endokrinol 1, Stuttgart, Germany

[5] Univ Jena, Klin Innere Med 3, Jena, Germany

[6] Diabet Zentrum Bad Lauterberg, Bad Lauterberg im Harz, Germany

[7] Krankenhaus Rudolfstiftung, Med Abt 1, Vienna, Austria

[8] St Vincentius Kliniken 1, Karlsruhe, Germany

来源：

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES | 2009年 / 117卷 / 09期

关键词：

DIPEPTIDYL PEPTIDASE-4 INHIBITOR; METFORMIN-TREATED PATIENTS; IMPROVES GLYCEMIC CONTROL; SULFONYLUREA PLUS METFORMIN; CARDIOVASCULAR RISK-FACTORS; ACUTE MYOCARDIAL-INFARCTION; DRUG-NAIVE PATIENTS; TO-TARGET TRIAL; PLASMINOGEN-ACTIVATOR INHIBITOR; INSULIN COMBINATION THERAPY;

D O I：

10.1055/s-0029-1239559

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

收藏

页码：522 / 557

页数：36

相关论文

共 286 条

[1] Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes: VA feasibility study on glycemic control and complications (VA CSDM) [J].

Abraira, C ;

Henderson, WG ;

Colwell, JA ;

Nuttall, FQ ;

Comstock, JP ;

Emanuele, NV ;

Levin, SR ;

Sawin, CT ;

Silbert, CK .

DIABETES CARE, 1998, 21 (04) :574-579

[2] Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes [J].

Ahrén, B ;

Gomis, R ;

Standl, E ;

Mills, D ;

Schweizer, A .

DIABETES CARE, 2004, 27 (12) :2874-2880

[3] Efficacy and safety of incretin therapy in type 2 diabetes - Systematic review and meta-analysis [J].

Amori, Renee E. ;

Lau, Joseph ;

Pittas, Anastassios G. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (02) :194-206

[4] Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus [J].

Anderson, JH ;

Brunelle, RL ;

Keohane, P ;

Koivisto, VA ;

Trautmann, ME ;

Vignati, L ;

DiMarchi, R .

ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (11) :1249-1255

[5] PLASMINOGEN-ACTIVATOR INHIBITOR-1 SYNTHESIS IN THE HUMAN HEPATOMA-CELL LINE HEP G2 - METFORMIN INHIBITS THE STIMULATING EFFECT OF INSULIN [J].

ANFOSSO, F ;

CHOMIKI, N ;

ALESSI, MC ;

VAGUE, P ;

JUHANVAGUE, I .

JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (05) :2185-2193

[6]

[Anonymous], 1999, Diabet Med, V16, P716

[7]

[Anonymous], N ENGL J MED

[8] Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes [J].

Aschner, Pablo ;

Kipnes, Mark S. ;

Lunceford, Jared K. ;

Sanchez, Matilde ;

Mickel, Carolyn ;

Williams-Herman, Debora E. .

DIABETES CARE, 2006, 29 (12) :2632-2637

[9] Effects of metformin in patients with poorly controlled insulin-treated type 2 diabetes mellitus -: A randomized, double-blind, placebo-controlled trial [J].

Avilés-Santa, L ;

Sinding, J ;

Raskin, P .

ANNALS OF INTERNAL MEDICINE, 1999, 131 (03) :182-+

[10] EFFECTIVENESS OF COMBINED GLIBENCLAMIDE AND INSULIN-TREATMENT OF PATIENTS WITH SECONDARY SULFONYLUREA FAILURE - A CONTROLLED MULTI-CENTER DOUBLE-BLIND TRIAL [J].

BACHMANN, W ;

LOTZ, N ;

MEHNERT, H ;

ROSAK, C ;

SCHOFFLING, K .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 113 (16) :631-636

← 1 2 3 4 5 6 7 8 9 10 →